While MIG-6 down-regulation is reported in a high percentage of papillary thyroid cancers [22], high MIG-6 expression correlates with longer survival and is associated with favorable surgical outcomes for those patients [24]. Here, ERRFI1 is linked to thyroid gland papillary carcinoma.